Connection
Michael Clay to Phthalazines
This is a "connection" page, showing publications Michael Clay has written about Phthalazines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.177 |
|
|
|
-
Federico SM, Pappo AS, Sahr N, Sykes A, Campagne O, Stewart CF, Clay MR, Bahrami A, McCarville MB, Kaste SC, Santana VM, Helmig S, Gartrell J, Shelat A, Brennan RC, Hawkins D, Godwin K, Bishop MW, Furman WL, Stewart E. A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies. Eur J Cancer. 2020 09; 137:204-213.
Score: 0.177